NKTR Trading Analysis - 11/06/2026 11:11 AM โ€” TRU-SENTIMENT

NKTR (Nektar Therapeutics) at $36.64. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $2,470 vs put $0. RSI 52.4.

TRU-SENTIMENT ยท DeltaNeutral

NKTR Trading Analysis - 11/06/2026 11:11 AM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

NKTR (Nektar Therapeutics) at $36.64. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $2,470 vs put $0. RSI 52.4.

Symbol
NKTR
Price
$36.64
Article bias (separate from True Sentiment)
neutral
Conviction
low
Published
2026-11-06 11:11:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

From NKTR_options_20261106 data:

Call Dollar Volume: 2470.00 (100.00%) Put Dollar Volume: 0.00 (0.00%) Total: 2470.00

Sentiment: Bullish (2 trades, 4 contracts, delta 40-60 filter). Pure directional call conviction with zero put activity. This diverges from bearish technicals (Option Spread advice: "Divergence detected between technical indicators and options sentiment"). Near-term expectations implied: modest bullish bet, but low sample (0.4% of 516 options analyzed).

Key Statistics: NKTR

$36.73 +1.46%
52-Week Range
$33.40 - $109.00
Market Cap
$1.25B
P/E (TTM)
4.50
PEG Ratio
N/A
Beta
1.34
Next Earnings
N/A
Avg Volume
$731,170
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

P/E (trailing)4.50
EPS (trailing 12 mo)$-2.87
Market cap$1.25B
Shares outstanding34.1M

Dividend

Dividend yield0.00%

Risk & range

Beta1.34
52-week low$33.40
52-week high$109.00
Historical volatility90.8%

Ownership & trading

Institutional ownership45.4%
Average daily volume0.8M sh

Reported figures; no analyst estimates.


๐Ÿ“ˆ Analysis

News Headlines & Context

The following context items are based on general knowledge of Nektar Therapeutics (NKTR) and are separated from the data-driven analysis below:

  • NKTR has historically been a clinical-stage biopharma name with pipeline readouts driving sharp volatility; recent years saw repositioning away from prior failed partnerships.
  • Potential near-term catalyst: upcoming December options expiration may coincide with year-end pipeline or cash-runway commentary.
  • Biotech sector sentiment has been mixed, with small-cap names facing liquidity pressure amid higher rates.
  • No confirmed earnings date in provided data, but historical fiscal year end is 2025-12-01 per fundamentals.
  • Headlines of dilution or deleveraging could relate to the steep Septโ€“Oct 2026 drawdown seen in daily history data.

Fundamental Analysis

Based strictly on the embedded FUNDAMENTALS data for NKTR:

  • Trailing P/E: 4.50 (note: trailing EPS is negative at -2.87, so P/E is non-meaningful / distorted).
  • Trailing EPS: -2.87, indicating the company is not profitable on a trailing basis.
  • Market Cap: 1,254,072,390.00; Shares Outstanding: 34,143,000.00.
  • Dividend Yield: 0.00; no dividend declared (ex-dividend date null).
  • Beta: 1.34 (above 1, suggests higher systemic volatility vs market).
  • 52-Week High: 109.00; 52-Week Low: 33.40 โ€” current price near lower bound.
  • Institutional Ownership: 45.41%.
  • Average Volume: 790,000.00; Historical Volatility: 90.78% (very elevated).
  • PEG Ratio, Forward P/E, Forward EPS, Profit Margins, ROE, Debt/Equity, Free Cash Flow, Revenue Growth, Total Revenue: all null in data.
  • Analyst consensus and target price: not available (recommendationKey null, targetMeanPrice null).

Fundamentals show a loss-making small-cap biotech with no dividend, high volatility, and unknown margins/leverage. This diverges from the bullish options sentiment but aligns with the bearish longer-term technical backdrop (price far below 50-day SMA of 52.70).

Current Market Position

From embedded data: current price per indicators is 36.20 (as of 2026-11-05). Minute bars show 2026-11-05 open 38.36, low 35.76, close 36.20; 2026-11-06 bars show drift from 36.93 down to 36.64 by 10:40. Recent daily history shows close fall from 57.83 (2026-09-25) to 36.20 (2026-11-05).

Intraday momentum (11-06) is mildly downward: open 36.93 โ†’ close 36.64, with lower highs/lows across last 5 minute bars. Volume on 11-05 was 411,343 vs 20-day avg 447,283 โ€” below average.

Technical Analysis

Technical Indicators

Current Price
36.20
SMA 5
37.54
SMA 20
37.92
SMA 50
52.70
RSI 14
52.39
MACD
-3.93
Signal
-3.14
Hist
-0.79
BB Mid
37.92
BB Up
40.37
BB Low
35.48
ATR 14
1.64
30d High
62.40
30d Low
35.61

Price (36.20) is below SMA 5 (37.54), SMA 20 (37.92), and far below SMA 50 (52.70): bearish alignment, no bullish crossover. RSI 52.39 is neutral, not oversold. MACD (-3.93) below signal (-3.14), histogram -0.79: bearish momentum. Bollinger mid 37.92, lower 35.48 โ€” price near lower band, slight expansion. 30-day range 35.61โ€“62.40; price sits at 1.5% above 30d low.

True Sentiment Analysis (Delta 40-60 Options)

From NKTR_options_20261106 data:

Call Dollar Volume: 2470.00 (100.00%) Put Dollar Volume: 0.00 (0.00%) Total: 2470.00

Sentiment: Bullish (2 trades, 4 contracts, delta 40-60 filter). Pure directional call conviction with zero put activity. This diverges from bearish technicals (Option Spread advice: "Divergence detected between technical indicators and options sentiment"). Near-term expectations implied: modest bullish bet, but low sample (0.4% of 516 options analyzed).

Key Price Levels (Observational Only)

Support (30d Low)
35.61
BB Lower
35.48
SMA 5
37.54
SMA 20 / BB Mid
37.92
BB Upper
40.37
SMA 50
52.70

Interactive charts load with JavaScript. This text is the crawlable summary.